Grupo Nutresa S. A.
Grupo Nutresa S. A. (GCHOY) Financial Performance & Income Statement Overview
Analyze Grupo Nutresa S. A. (GCHOY) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Grupo Nutresa S. A. (GCHOY) Income Statement & Financial Overview
Review Grupo Nutresa S. A. GCHOY income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $4872.79B | $5071.55B | $4750.30B | $4461.14B |
| Cost of Revenue | $2985.18B | $3162.80B | $2905.15B | $2684.91B |
| Gross Profit | $1887.61B | $1908.75B | $1845.15B | $1776.23B |
| Gross Profit Ratio | $0.39 | $0.38 | $0.39 | $0.40 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1310.20B | $1134.35B | $1379.96B | $1337.46B |
| Operating Expenses | $1285.34B | $1462.82B | $1367.67B | $1337.46B |
| Total Costs & Expenses | $4270.52B | $4625.62B | $4272.81B | $4022.37B |
| Interest Income | $25.41B | -$4.70B | $14.83B | $13.27B |
| Interest Expense | $177.46B | $164.63B | $137.48B | $195.73B |
| Depreciation & Amortization | $0.00 | $242.005B | $83.64B | $129.21B |
| EBITDA | $598.45B | $656.42B | $551.59B | $567.98B |
| EBITDA Ratio | $0.12 | $0.13 | $0.12 | $0.13 |
| Operating Income | $602.27B | $445.93B | $477.49B | $438.77B |
| Operating Income Ratio | $0.12 | $0.09 | $0.10 | $0.10 |
| Other Income/Expenses (Net) | -$181.28B | -$170.04B | -$151.13B | -$173.48B |
| Income Before Tax | $420.99B | $275.89B | $326.36B | $265.29B |
| Income Before Tax Ratio | $0.09 | $0.05 | $0.07 | $0.06 |
| Income Tax Expense | $122.38B | $98.44B | $110.99B | $100.45B |
| Net Income | $237.46B | $173.74B | $211.62B | $161.11B |
| Net Income Ratio | $0.05 | $0.03 | $0.04 | $0.04 |
| EPS | $518.75 | $379.54 | $462.30 | $351.96 |
| Diluted EPS | $518.75 | $379.54 | $462.30 | $351.96 |
| Weighted Avg Shares Outstanding | $457.76M | $457.76M | $457.76M | $457.76M |
| Weighted Avg Shares Outstanding (Diluted) | $457.76M | $457.76M | $457.76M | $457.76M |
The company's financials show resilient growth, with revenue advancing from $4461.14B in Q2 2024 to $4872.79B in Q1 2025. Gross profit remained healthy with margins at 39% in Q1 2025 compared to 40% in Q2 2024. Operating income hit $602.27B last quarter, sustaining a consistent 12% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $598.45B. Net income rose to $237.46B, while earnings per share reached $518.75. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan